ROIV

ROIVANT SCIENCES LTD

ROIV·G76279101·US·Common Stock·Healthcare - Biotechnology-13D/G

ROIV (ROIVANT SCIENCES LTD) is held by 210 institutional investors as of Q2 2026. Largest holders: FMR LLC ($2.9B), BlackRock, Inc. ($1.7B), MORGAN STANLEY ($1.5B). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 128 funds bought ROIV.

210
Holders
(16 Elite)
$16.3B
Total Value
60% (214)
Consensus
128 buying - 86 selling
13F: Insider & Congress: Updated regularly
ROIV

Smart Money Verdict

View all
Loading verdict
Held by 210 funds
16 elite

Who's Trading

Source dates: Price Oct 14, 2026 · Insiders Oct 5, 2026 · Activists Aug 13, 2026 · Congress Nov 21, 2025

InsiderEBEpperly Melissa B,Exercise 18K shOct 1, 2026
InsiderEBEpperly Melissa B,Sell $608KOct 1, 2026
InsiderEBEpperly Melissa B,Sell $33KOct 1, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
81M(+3.9%)$2.9B0.1%+136.73%
40
Increased
48.2M(+9.0%)$1.7B0.0%+127.73%
35
Decreased
42.6M(-17.8%)$1.5B0.1%+150.42%
0
Increased
22.1M(+7.0%)$782.9M0.0%+18.62%
34
Increased
21.6M(+9.1%)$765.9M0.0%+18.06%
35
Increased
18.6M(+67.0%)$656.7M0.1%+30.09%
46
Increased
17.8M(+9.9%)$629.8M0.0%+180.47%
35
Decreased
17.5M(-22.8%)$618.1M0.1%+56.25%
0
Increased
14.3M(+47.9%)$506.4M2.3%+11.15%
74
Increased
11.7M(+14.7%)$425.5M0.0%+97.46%
36
Decreased
10.3M(-19.1%)$366.3M0.5%+88.49%
0
Increased
8.4M(+18.2%)$296M0.4%+41.43%
43
Increased
7.5M(+17.0%)$266.5M0.0%+36.89%
36
Increased
6.6M(+11.6%)$234M0.1%+21.22%
34
Decreased
6.3M(-5.7%)$221.9M0.6%+200.68%
0
Increased
5.6M(+121.6%)$197.3M0.0%+20.17%
49
Decreased
5.2M(-30.0%)$185.1M0.0%+187.86%
0
Decreased
4.8M(-31.1%)$170.5M0.0%+71.51%
0
Decreased
4.7M(-3.1%)$166.9M0.8%+146.82%
0
Increased
4.5M(+50.3%)$158.6M0.1%+24.03%
42

Showing 1-20 of 219

1 / 11
ROIVROIVROIVANT SCIENCES LTD

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used